Quisinostat
Product Specifications
CAS Number
875320-29-9
Target
Apoptosis, Autophagy, HDAC
Related Pathways
Apoptosis, Chromatin/Epigenetic, DNA Damage/DNA Repair, Autophagy
Purity
0.9801
Bioactivity
Quisinostat (JNJ-26481585) (JNJ-26481585) is a novel second-generation HDAC inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7.
Smiles
Cn1cc(CNCC2CCN(CC2)c2ncc(cn2)C(=O)NO)c2ccccc12
Molecular Formula
C21H26N6O2
Molecular Weight
394.47
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
043969-APC 200 µL
YTHD2, CT (YTHDF2, HGRG8, YTH domain family protein 2, CLL-associated antigen KW-14, High-glucose-regulated protein 8, Renal carcinoma antigen NY-REN-2) (APC) discontinued
Sign In for Pricing
View Details 
A08425-1-Dylight550 100 µg
Anti-SARS2 Antibody Picoband®, Dylight550 Conjugate
Sign In for Pricing
View Details MBS1130925-01 0.05 mg (E-Coli)
Recombinant Notophthalmus viridescens Thyroliberin
Sign In for Pricing
View Details MBS1130925-02 0.2 mg (E-Coli)
Recombinant Notophthalmus viridescens Thyroliberin
Sign In for Pricing
View Details